Arcus Biosciences, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Hayward CA United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03629756
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Arcus Biosciences | Arcus Biosciences, Inc.